The earlier, the better: the effects of different administration timepoints of sorafenib in suppressing the carcinogenesis of VEGF in rats
Crossref DOI link: https://doi.org/10.1007/s00280-017-3493-4
Published Online: 2017-12-01
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Nan
Chen, Bin
Lin, Run
Liu, Ni
Dai, Hai-tao
Tang, Ke-yu
Yang, Jian-yong
Huang, Yong-hui
Funding for this research was provided by:
Wu Jieping Medical Foundation (320.6750.14800)
License valid from 2017-12-01